Venlafaxine Hydrochloride
Product Images NDC 71921-173

14 FDA label images from Florida Pharmaceutical Products, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 71921-173). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Florida Pharmaceutical Products, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (F06f84fb B574 4f19 Bf21 5ae0c56c2116 38 1)

Image (F06f84fb B574 4f19 Bf21 5ae0c56c2116 38 1)
The image shows the front panel of a medication package for VENLAFAXINE HYDROCHLORIDE labeled by Florida Pharmaceutical Products, LLC. The label includes the proprietary name prominently, but no dosage strength, form, or quantity is visibly detailed in the image provided.*
FDA Label Image

Image (F06f84fb B574 4f19 Bf21 5ae0c56c2116 38 2)

Image (F06f84fb B574 4f19 Bf21 5ae0c56c2116 38 2)
VENLAFAXINE HYDROCHLORIDE label from Florida Pharmaceutical Products, LLC. The label is primarily green and white with the proprietary name in bold. It appears to be a medication packaging label but contains no visible information on strength, dosage form, or package size.*
FDA Label Image

Image (F06f84fb B574 4f19 Bf21 5ae0c56c2116 38 3)

Image (F06f84fb B574 4f19 Bf21 5ae0c56c2116 38 3)
Packaging label for VENLAFAXINE HYDROCHLORIDE manufactured by Florida Pharmaceutical Products, LLC. The label includes the drug name and some prescription and regulatory information, displayed on a white background with blue and yellow elements.*
FDA Label Image

Image (F06f84fb B574 4f19 Bf21 5ae0c56c2116 01)

Image (F06f84fb B574 4f19 Bf21 5ae0c56c2116 01)
A dot plot chart illustrating pharmacokinetic changes in drug interactions with venlafaxine hydrochloride. It shows changes in Cmax and AUC values for several interacting drugs such as ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, desipramine, haloperidol, caffeine, toltubamide, and lithium. The chart includes recommendations for dose adjustments or precautions based on the interaction analysis.*
FDA Label Image

Image (F06f84fb B574 4f19 Bf21 5ae0c56c2116 02)

Image (F06f84fb B574 4f19 Bf21 5ae0c56c2116 02)
Chemical structure diagram of venlafaxine hydrochloride showing molecular bonds, functional groups including a methoxy-substituted phenyl ring, a cyclohexane ring, and an amine group as part of the molecule.*
FDA Label Image

Image (F06f84fb B574 4f19 Bf21 5ae0c56c2116 03)

Image (F06f84fb B574 4f19 Bf21 5ae0c56c2116 03)
A scatter plot depicting fold change and 90% confidence intervals for venlafaxine and its metabolite ODV across various special populations (hepatic impairment, renal impairment, CYP2D6 metabolism status, age, and gender). The x-axis shows change relative to reference values, illustrating pharmacokinetic variability (Cmax and AUC) among these groups.*
FDA Label Image

Image (F06f84fb B574 4f19 Bf21 5ae0c56c2116 04)

Image (F06f84fb B574 4f19 Bf21 5ae0c56c2116 04)
A chart depicting the pharmacokinetic fold change and 90% confidence intervals for venlafaxine when interacting with various drugs. The X-axis shows the change relative to the reference value, ranging from 0 to 3. The Y-axis lists interacting drugs and analytes with pharmacokinetic parameters Cmax and AUC, including ethanol, diazepam, cimetidine, ketoconazole (in CYP2D6 EM's and PM's), indinavir, metoprolol, imipramine, and lithium. Data points indicate fold changes with confidence intervals for each drug interaction.*
FDA Label Image

Image (F06f84fb B574 4f19 Bf21 5ae0c56c2116 05)

Image (F06f84fb B574 4f19 Bf21 5ae0c56c2116 05)
A pharmacokinetic fold change chart comparing the impact of various interacting drugs and their analytes on parameters Cmax and AUC. The horizontal axis shows change relative to a reference value, with dots and confidence intervals representing fold changes and 90% confidence intervals for drugs including Ethanol, Diazepam, Alprazolam, Indinavir, Metoprolol, Risperidone, Imipramine, Haloperidol, Caffeine, Tolbutamide, and Lithium.*
FDA Label Image

Image (F06f84fb B574 4f19 Bf21 5ae0c56c2116 181 1)

Image (F06f84fb B574 4f19 Bf21 5ae0c56c2116 181 1)
VENLAFAXINE HYDROCHLORIDE bottle label from Florida Pharmaceutical Products, LLC. The label shows the product name VENLAFAXINE HYDROCHLORIDE in large text. The label includes the company's name and logo. The container appears to be a small white plastic bottle with a white cap. No strength, dosage form, or quantity information is clearly visible in the image.*
FDA Label Image

Image (F06f84fb B574 4f19 Bf21 5ae0c56c2116 181 2)

Image (F06f84fb B574 4f19 Bf21 5ae0c56c2116 181 2)
VENLAFAXINE HYDROCHLORIDE capsules in a clear blister pack with silver foil backing. The image shows ten capsules arranged in two rows of five. No dosage strength or additional labeling details are visible. The product is from Florida Pharmaceutical Products, LLC.*
FDA Label Image

Image (F06f84fb B574 4f19 Bf21 5ae0c56c2116 181 3)

Image (F06f84fb B574 4f19 Bf21 5ae0c56c2116 181 3)
VENLAFAXINE HYDROCHLORIDE capsule blister pack showing multiple capsules. The capsules are red and white and arranged in two rows on a foil backing. The labeler is Florida Pharmaceutical Products, LLC. No strength or dosage information is visible.*
FDA Label Image

Venlafaxine-05 (F06f84fb B574 4f19 Bf21 5ae0c56c2116 06)

Venlafaxine-05 (F06f84fb B574 4f19 Bf21 5ae0c56c2116 06)
Label for Venlafaxine HCl Extended-release Capsules, USP, with strength 37.5 mg, in a 30-capsule package. The label indicates storage instructions, manufacturer Inventia Healthcare Limited in India, and labeler Florida Pharmaceutical Products, LLC in Boca Raton, FL. Includes barcode and pharmacist dispensing note.*
FDA Label Image

Venlafaxine-06 (F06f84fb B574 4f19 Bf21 5ae0c56c2116 07)

Venlafaxine-06 (F06f84fb B574 4f19 Bf21 5ae0c56c2116 07)
Label for Venlafaxine HCl Extended-release Capsules, USP, 75 mg, supplied in a 30-capsule package. The label includes dosing and storage instructions, pharmacist dispensing guidance, the NDC number 71921-173-33, and manufacturing information for Florida Pharmaceutical Products, LLC. The label also features a barcode and areas designated for additional product tracking details.*
FDA Label Image

Venlafaxine-07 (F06f84fb B574 4f19 Bf21 5ae0c56c2116 08)

Venlafaxine-07 (F06f84fb B574 4f19 Bf21 5ae0c56c2116 08)
Label for Venlafaxine HCl extended-release capsules, USP 150 mg, manufactured for Florida Pharmaceutical Products, LLC. The label indicates 30 capsules per package, includes storage instructions between 20 to 25°C, and mentions this is for prescription use only (Rx only). Manufacturer details include Inventia Healthcare Limited in India. Barcodes and a pharmacist dispensing note are also shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.